Cas 66868-65-3,(5-cyclohexylmethanesulfinyl-1<sup>(3)</sup><i>H</i>benzoimidazol-2-yl)-carbamic acid methyl ester

66868-65-3

Post Buying Request

Basic information

Product Name: (5-cyclohexylmethanesulfinyl-1⁽³⁾Hbenzoimidazol-2-yl)-carbamic acid methyl ester
Synonyms: (5-cyclohexylmethanesulfinyl-1⁽³⁾Hbenzoimidazol-2-yl)-carbamic acid methyl ester
CAS NO:66868-65-3
Molecular Formula:
Molecular Weight: 335.427
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (5-cyclohexylmethanesulfinyl-1⁽³⁾Hbenzoimidazol-2-yl)-carbamic acid methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (5-cyclohexylmethanesulfinyl-1⁽³⁾Hbenzoimidazol-2-yl)-carbamic acid methyl ester(66868-65-3)
EPA Substance Registry System: (5-cyclohexylmethanesulfinyl-1⁽³⁾Hbenzoimidazol-2-yl)-carbamic acid methyl ester(66868-65-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 66868-65-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

66868-65-3 Suppliers

Recommended suppliers

66868-65-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 66868-65-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,8,6 and 8 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 66868-65:
(7*6)+(6*6)+(5*8)+(4*6)+(3*8)+(2*6)+(1*5)=183
183 % 10 = 3
So 66868-65-3 is a valid CAS Registry Number.

66868-65-3Upstream product

63667-13-0 [5-[(cyclohexylmethyl)thio]-1H-benzimidazol-2-yl]carbamic acid,methyl ester

66868-65-3Downstream Products

66868-65-3Relevant academic research and scientific papers

Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles

-

, (2008/06/13)

A method is provided for treating or inhibiting helminthiasis by parenterally administering sulfoxide derivatives of benzimidazoles having the structure STR1 wherein R1 is lower alkyl or phenyl-lower alkyl, R2 and R3 may be the same or different and are hydrogen or lower alkyl, R4 is cycloalkyl, and m is 0 to 3, n is 0 to 3, m + n being ≤ 5. Pharmaceutical compositions for use in the above method are also provided.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 66868-65-3